GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aditxt ADTX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

-28.57%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Aditxt — daily ADTX Delayed
Market value
$0
Last close × shares
Volume
9.8m
Shares, 9 Nov 2026

About Aditxt

Its shares trade under the ticker ADTX. It has been listed since 19 June 2020. In the fiscal year to 31 December 2025, it reported revenue of $3,195 and a net loss of $41.7m. At that date it held total assets of $16.5m and shareholders' equity of $5.6m.

ADiTx Therapeutics, Inc. is a preclinical stage, life sciences company which engages in the development of nucleic acid (DNA)-based technologies to minimize rejection of transplanted organs by human recipients as well as address autoimmune diseases and allergies. The company is headquartered in Mountain View, California. The company went IPO on 2020-06-19. The firm is focused on developing technologies on improving the health of the immune system through immune reprogramming and monitoring. The Company’s immune reprogramming technology is at the pre-clinical stage and is designed to retrain the immune system to induce tolerance. The Company’s immune monitoring technology is designed to provide a personalized profile of the immune system. The firm is developing nucleic acid-based technology, Apoptotic DNA Immunotherapy (ADi) that mimics the way human body naturally induces tolerance to its tissues. The firm is developing Aditxt Immune Monitor (AiM), which provides a personalized comprehensive profile of the immune system.

Figures and description from our data supplier, not checked against the company's own report.

More about Aditxt →

Latest on Aditxt

Our reporting

We have not reported on Aditxt yet.

Next results

16 Nov 2026

Due on 16 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Aditxt's ticker?

Aditxt trades as ADTX on its US listing, under ISIN US0070258852.

What was Aditxt's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

When does Aditxt next report results?

Results are expected on 16 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.